โ… . Introduction

  • ์•”์„ ๋ฐœ์ƒ์‹œํ‚ค๋Š” tumor virus.

  • ์•” ๋ฐœ์ƒ์„ ๋ง‰๊ธฐ ์œ„ํ•ด ๋ฐฑ์‹ ์„ ๊ฐœ๋ฐœ (๋ฐฑํ˜ˆ๋ณ‘์˜ ๊ฒฝ์šฐ ์•”์„ ๋ง‰๊ธฐ ์œ„ํ•ด ํ’ˆ์ข…์„ ๊ฐœ๋Ÿ‰)

  • ๋‹ญ์—์„œ ํ”ํ•˜๊ณ , ์น ๋ฉด์กฐ์™€ ๋ฉ”์ถ”๋ผ๊ธฐ์—์„œ๋Š” ๋“œ๋ฌผ๋‹ค.

  • ์ „ํŒŒ๋ ฅ์ด ๊ฐ•ํ•จ. ๋ฐœ์•”์„ฑ. ==cell-associated==-์„ธํฌ๋ฅผ ๋ฒ—์–ด๋‚˜๋ฉด ๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€ ์ฃฝ์–ด๋ฒ„๋ฆผ.

  • primary target cells : spleen, bursa, thymus์˜ B์„ธํฌ

  • lymphoprolifrative(๋ฆผํ”„์ ˆ ์ฆ์‹), neuropathic(์‹ ๊ฒฝ ์นจํ•ด์„ฑ) ์งˆ๋ณ‘

  • ๋ง์ดˆ ์‹ ๊ฒฝ์˜ ๋‹จํ•ต๊ตฌ ์นจ์ž…(mononuclear infiltration). ํ™์ฑ„์™€ ํ”ผ๋ถ€๋ฅผ ํฌํ•จํ•œ ์žฅ๊ธฐ ๋˜๋Š” ์กฐ์ง์— ์˜ํ–ฅ์„ ๋ฏธ์นจ.

  • ๋‚ด์žฅ ๋ฆผํ”„์ข…์ฆ, ํ”ผ๋ถ€ ๋ฆผํ”„์ข…์ฆ, ์ผ์‹œ์  ๋งˆ๋น„, early mortality syndrome(10์ผ ๋งŒ์— ํ์‚ฌ^[๋ณดํ†ต cancer๋Š” 15-16์ฃผ์—์„œ ๋‚˜ํƒ€๋‚จ]), ์„ธํฌ ์šฉํ•ด์„ฑ ๊ฐ์—ผ, ์˜๊ตฌ์  ์‹ ๊ฒฝ ์งˆํ™˜.

  • ๋ฐฑ์‹ ์€ 1970๋…„๋Œ€๋ถ€ํ„ฐ ๊ฐœ๋ฐœ, 100% ๋ฐฉ์ง€๋Š” ๋ชปํ•˜์ง€๋งŒ ์†์‹ค์„ ๊ฒฝ๊ฐ์‹œํ‚ด.

  • vaccination break๊ฐ€ ๋ฐœ์ƒํ•  ์ˆ˜ ์žˆ๋‹ค. (๋ฐฑ์‹  ์ ‘์ข…์„ ์™„๋ฃŒํ–ˆ์ง€๋งŒ, ์งˆ๋ณ‘์ด ๋ฐœ์ƒํ•˜๋Š” ๊ฒƒ. ๋ณ€์ด ๋ฐ”์ด๋Ÿฌ์Šค ๋“ฑ์œผ๋กœ ์ธํ•จ)

  • mortality : ์œก๊ณ„ < ์‚ฐ๋ž€๊ณ„ (์œก๊ณ„๋Š” cancer๊ฐ€ ๋ฐœ์ƒํ•˜๊ธฐ ์ „ ์–ด๋ฆฐ ๋‚˜์ด-30์ผ๋ น-์— ๋„์ถ•๋˜๊ธฐ ๋•Œ๋ฌธ)

  • Visceral lymphomatosis, acute leukosis, blindness, uveitis(ํฌ๋„๋ง‰์—ผ), iritis(ํ™์ฑ„์—ผ), gray eye, ocular lymphomatosis ๋ผ๊ณ ๋„ ํ•œ๋‹ค. (๋ฐฑํ˜ˆ๋ณ‘๊ณผ ์ฆ์ƒ ์œ ์‚ฌ, ๋ˆˆ ์ชฝ์— ๋ฌธ์ œ ๅคš)

โ…ก. History

1) ์—ญ์‚ฌ

  • 1907 : Marek - ๋‚ ๊ฐœ์™€ ๋‹ค๋ฆฌ์—์„œ ๋งˆ๋น„๊ฐ€ ์ผ์–ด๋‚˜๋Š” case ๋ฐœ๊ฒฌ
  • MD์™€ LL์˜ ๋ณ‘๋ณ€์ด ๋น„์Šทํ•˜๊ณ , ์—ผ์ฆ์„ฑ์ธ์ง€ ๋ฐœ์•”์„ฑ์ธ์ง€ ๋…ผ์Ÿ
  • 1926 : tumor๋ฅผ ํ˜•์„ฑํ•˜๋Š” ์‹ ์ƒ๋ฌผ ์งˆํ™˜
  • 1950s : โ€œvisceral lymphomatosisโ€, โ€œacute leukosisโ€ ๋“ฑ์œผ๋กœ ํผ์ง
  • 1967 : Herpesvirus์— ์˜ํ•œ ๊ฒƒ์ž„์„ ๋ฐํž˜.

2) ๋ฐœ์ƒ

  • ๋ณ‘์›์„ฑ์— ๋”ฐ๋ผ 4๊ฐ€์ง€๋กœ ๋ถ„๋ฅ˜ํ•จ.
๋ณ‘์›์„ฑ๋ฐœ์ƒํŠน์ง•
Mild (mMDV)1907
~
1950์ดˆ๋ฐ˜
- ์ฃผ๋กœ ์‹ ๊ฒฝ ๋ฌธ์ œ(๋งˆ๋น„) ๋ฐœ์ƒ
- tumor ๋ฐœ์ƒ์€ ์ ์—ˆ์Œ
- ๋ง์ดˆ ์‹ ๊ฒฝ์˜ gross enlargement
Virulent (vMDV)1950 ํ›„๋ฐ˜
~
1960๋…„๋Œ€
- ์กฐ๊ธˆ ๋” ๊ฐ•ํ•œ ๋ณ‘์›์„ฑ
- layer์—์„œ 40%, broiler์—์„œ 10%์˜ mortality
- ์‹ ๊ฒฝ ๋ณ‘๋ณ€ ์ฆ์ƒ๋„ ์žˆ์ง€๋งŒ, ๋‚ด์žฅ ์žฅ๊ธฐ์˜ ๋ฆผํ”„์ข…์ด ๋” ์ฃผ๋œ ์ฆ์„ธ
- โ€œacute leukosisโ€ or โ€œacute MDโ€
- Turkey herpesvirus(HVT)๋ฅผ ์ด์šฉํ•œ ๋ฐฑ์‹ (JM, GA, HPRS-16)์œผ๋กœ ์˜ˆ๋ฐฉ
Very virulent (vvMDV)1970 ํ›„๋ฐ˜- ๋” ๊ฐ•ํ•œ ๋ณ‘์›์„ฑ (HVT ๋ฐฑ์‹ ์œผ๋กœ๋Š” ์ž˜ ์˜ˆ๋ฐฉX)
- ๋‹ค๋ฅธ ์ข…์„ ์ด์šฉํ•œ ๋ฐฑ์‹ (HVT + SB-1)์œผ๋กœ ์˜ˆ๋ฐฉ๋จ.
- ๋Œ€ํ‘œ์ ์ธ ๋ฐฑ์‹  ์ด๋ฆ„์€ Md5
Very virulent plus (vv+MDV)1990๋…„๋Œ€
(Korea:1996)
- (HVT + CVI988)์˜ ์กฐํ•ฉ์œผ๋กœ ์˜ˆ๋ฐฉ๋จ. ๋ฐฑ์‹  ์ด๋ฆ„์€ 584A.

โ…ข. Etiology

1) Classification

  • Family Herpesviridae
    • SubFamily Alphaherpesvirinae
      • Genus Mardivirus
  • 3 serotypes ์กด์žฌ
    • ์„ธ ํ˜ˆ์ฒญํ˜•์€ ๋น„์Šทํ•˜๊ฒŒ ๊ตฌ์„ฑ๋˜์–ด ๋ฐฑ์‹ ์— serotype 2, 3 ๋“ฑ์ด ์‚ฌ์šฉ๋  ์ˆ˜ ์žˆ๋‹ค.
Serotype 1๋ณ‘์›์„ฑ ๊ฐ€์ง
mMDV, vMDV, vvMDV, vv+MDV
๋ฐฑ์‹ ์— ์‚ฌ์šฉ๋œ CVI988/Rispense๋„ ์†ํ•จ, ๋ณ‘์›์„ฑ ์—†์Œ
Serotype 2๋ฐฑ์‹ ์— ์‚ฌ์šฉ๋จ, SB-1
Serotype 3๋ฐฑ์‹ ์— ์‚ฌ์šฉ๋จ, HVT

2) Properties

  • dsDNA, 160~180kb

    • UL์ด TRL & IRL regions ์˜†์— ์žˆ์Œ
    • US๊ฐ€ TRS & IRS ์˜†์— ์žˆ์Œ
  • Hexgonal nucleocapsid : ์ง€๋ฆ„ 100nm / enveloped : 140-160bm

  • ๋ณ‘์›์„ฑ์ด ๊ฐ•ํ• ์ˆ˜๋ก genome size๊ฐ€ ํฐ ๊ฒฝํ–ฅ์„ ๊ฐ€์ง„๋‹ค. (serotype 1 > 2 > 3)

  • ์œ ์ „์ฒด๊ฐ€ ํฐ ํŽธ โ†’ ๋‹จ๋ฐฑ์งˆ๋„ ๋งŽ์ด encode

    • 65-68๊ฐœ ๋‹จ๋ฐฑ์งˆ์€ ์ธ๊ฐ„์˜ HSV์™€ ๋น„์Šท, 13-26๊ฐœ๋Š” MDV ๊ณ ์œ 
    • oncogenicity-related genes : 132 base pair repeats๋Š” tumor์™€ ๊ด€๋ จ๋˜์–ด ๋ณ‘์›์„ฑ ๊ฐ๋ณ„ํ•  ๋•Œ ์‚ฌ์šฉ.
      • pp38 : ์ข…์–‘ ๊ด€๋ จ ์œ ์ „์ž (38kd Phsphoprotein)

      • meq : ์ข…์–‘ ๊ด€๋ จ ์œ ์ „์ž (Marekโ€™s EcoQ)

    132 base pair repeats

    • virulent strain์—์„œ few copies, attenuated strain์—์„œ multiple copies๋ฅผ ๊ฐ–๋Š”๋‹ค.
    • serotype 1์—์„œ oncogenic strain / attenuated strain ์ค‘ ์–ด๋–ค ๊ฒŒ ์งˆ๋ณ‘์ด๊ณ  ์–ด๋–ค ๊ฒŒ ๋ฐฑ์‹ ์ธ์ง€ ๊ฐ๋ณ„ ํ•„์š” : 132bp related gene์„ ๊ฐ€์ง€๋ฉด attenuated ์•ˆ ๋œ ๊ฒƒ. >- ์ฆ‰, band ์ ์Œ = ๋ณ‘์›์„ฑ, band ๋งŽ์Œ = ๋ณ‘์›์„ฑ ๋œํ•จ(๋ฐฑ์‹ ์ฃผ)
    • glycoprotein genes (Late genes)
      • gC gene : ์„ธํฌ์—์„œ ๋‚˜์˜ค๋Š” A antigen์„ encode
      • gB gene : B antigen์„ encode, ํ•ญ์ฒด ์ค‘ํ™”(neutralizing Ab)์™€ ๊ด€๋ จ, ํ˜ธํก๊ธฐ ์ˆ˜์šฉ์ฒด ์ ‘์ฐฉ(์ถ”์ธก)
      • gD gene : cell-associated ์„ฑ์งˆ์— ๊ด€์—ฌ.
    • other genes
      • UL46, UL47, UL48, UL49 : tegument proteins๋ฅผ ๋ฐœํ˜„ (Unique Long)
      • ICP4 : latency ๊ด€๋ จ
      • TK(thymidine kinase), Ribonucleotide reductase, DNA polymerase
      • SORF1, SORF2, SORF3
  • ์„ธํฌ์งˆ๋ณด๋‹ค๋Š” ํ•ต์—์„œ ๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€ ์ฆํญ ๋ฐ ์กฐ๋ฆฝ

  • ์•ˆ์ „์„ฑ

    • MDV & HVT : cell-associated or cell-free
      • cell-associated : -196๋„ ๋ณด๊ด€
      • cell-free : -70๋„ ๋ณด๊ด€^[์ฐธ๊ณ : pH3์—์„œ 10๋ถ„ ์ฒ˜๋ฆฌํ•ด์„œ ๋ถˆํ™œํ™”]
    • ์ผ๋ฐ˜์ ์œผ๋กœ MDV๋Š” cell-associated virus์ด์ง€๋งŒ, ์œ ์ผํ•˜๊ฒŒ FFE(feather follicle epithelium)์—์„œ cell free virus๋กœ ์กด์žฌํ•จ. (์ƒˆ์˜ ๊นƒํ„ธ์„ ๋ˆŒ๋ €์„ ๋•Œ ๋‚˜์˜ค๋Š” ์•ก์ฒด์— ์žˆ๋Š” ๋ฐ”์ด๋Ÿฌ์Šค๋Š” cell-free๋กœ, ์ƒ๋Œ€์ ์œผ๋กœ ์žฅ๊ธฐ๊ฐ„ ๋ณด๊ด€ ๊ฐ€๋Šฅ.)

3) Virus replication

  • initial infection : ํ˜ธํก๊ธฐ๋ฅผ ํ†ตํ•ด cell-free virus๊ฐ€ ๋“ค์–ด์˜จ๋‹ค.
    • gB๊ฐ€ ํ˜ธํก๊ธฐ receptor ์ ‘์ฐฉ ์—ญํ• ์„ ํ•  ๊ฒƒ์œผ๋กœ ์˜ˆ์ƒ
  • replication ์†๋„ : ํ˜ˆ์ฒญํ˜•, virus strain์˜ ๋‹จ๊ณ„์— ๋”ฐ๋ผ ๋‹ฌ๋ผ์งˆ ์ˆ˜ ์žˆ๋‹ค.
  • ๊ฐ์—ผ ํ›„ cell to cell spread๋Š” ๋น ๋ฅด์ง€ ์•Š์€ ํŽธ.
  • virus-cell interaction์˜ 3๊ฐ€์ง€ ์œ ํ˜•์ด ์กด์žฌ
Virus-cell interactionํŠน์ง•
Productive infection์‚ด์•„ ์žˆ๋Š” ๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€ ๊ฐ์—ผ์„ฑ์„ ๊ฐ€์ง€๊ณ  ๋‚˜์˜ด. ๋ณต์ œ๋ณธ์€ 1200๋ฐฐ๊นŒ์ง€ ๊ฐ€๋Šฅ.
๋Œ€๋ถ€๋ถ„์˜ MDV gene์€ ์ „์‚ฌ๋˜๋ฉฐ, ์ „์‚ฌ๋œ vRNA๊ฐ€ ํ•ต๊ณผ ์„ธํฌ์งˆ์—์„œ
i) Fully productive infection๊ฐ์—ผ๋ ฅ ์žˆ๋Š” ๋ฐ”์ด๋Ÿฌ์Šค ์ž์ฒด๊ฐ€ ๋ณต์ œ๋˜์–ด ๋‚˜์˜ด. ์™ธํ”ผ๋กœ ๊ฐ์‹ธ์ ธ ๋‚˜์˜ด.
- MDV์˜ ๊ฒฝ์šฐ, ์ด virus ํ˜•ํƒœ๋Š” FFE์—์„œ๋งŒ ๋ฐœ๊ฒฌ๋จ.
ii) Productive-restrictive infectionnoneveloped ํ˜•ํƒœ์˜ ๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€ ์„ธํฌ ์•ˆ์— ์กด์žฌํ•˜๋ฉด์„œ ์ฆ์‹.
- MDV์˜ ์ฃผ๋œ ํ˜•ํƒœ.
Latent infection๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€ ์—ฌ์ „ํžˆ ์ฒด๋‚ด์— ๋‚จ์•„์žˆ๋Š” ๊ฒฝ์šฐ.
- protein์„ ๋” ์ด์ƒ ๋งŒ๋“ค์ง€ ์•Š๋Š” nonproductive ์ƒํƒœ
- viral genome ์ค‘์— 5 copies๋งŒ ์กด์žฌ
- ==CD4+ T cells==์— ๋ฐ”์ด๋Ÿฌ์Šค ์ž ๋ณต.
โ‡’ T cell์ด ์–ต์ œ๋˜๋Š” ๋ฉด์—ญ์–ต์ œ์ œ ์ƒํ™ฉ์—์„œ ์„ ํƒ์ ์œผ๋กœ reactivation๋จ.
(cyclosporine, betamethasone, chicken anemia virus ๋“ฑ)
- ์ผ๋ถ€ gene ์ „์‚ฌ O / ๋ฒˆ์—ญ X
Transforming infectioncancer๋ฅผ ๋งŒ๋“œ๋Š” infection.
- serotype 1์—์„œ๋งŒ ๋ฐœ์ƒ. target cell์€ T cell.
- 5-15 copies๋ฅผ ํฌํ•จํ•จ. ์„œ์„œํžˆ ์ง„ํ–‰๋จ.
- ์ข…์–‘ ์„ธํฌ์—์„œ๋Š” **MATSA(MD tumor-associated surface antigen)**์ด ๋ฐœ๊ฒฌ๋จ.

4) Strain Classification

  • ํŒ๋ณ„ : type-specific Mab, ์œ ์ „์ž ๊ฐ๋ณ„(์ตœ๊ทผ)
  • serotype์— ๋”ฐ๋ผ ๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€ ์ž˜ ์ž๋ผ๋Š” ์„ธํฌ์˜ ์ข…๋ฅ˜์™€ ํ˜•์„ฑํ•˜๋Š” plaque์˜ ํฌ๊ธฐ๊ฐ€ ๋‹ค๋ฆ„
ํ˜ˆ์ฒญํ˜•๋ฐฐ์–‘ ์„ธํฌplaque ํฌ๊ธฐ
serotype 1DEF(duck embryo fibroblast),
CKC(chickien kidney cell)
small
serotype 2CEFmedium
serotypeCEFlarge

5) Laboratory Host System

  • 1์ผ๋ น ๋ณ‘์•„๋ฆฌ
  • Chicken embryo
  • yolk : 4์ผ๋ น
  • CAM์—์„œ virus pocks ๊ด€์ฐฐ

โ…ฃ. Pathogenesis

1) Clinical signs

  • ๋ถ€๊ฒ€ ๊ด€์ฐฐ : 4์ฃผ๋ น๋ถ€ํ„ฐ tumor ๊ด€์ฐฐ ๊ฐ€๋Šฅ / ์ผ๋ฐ˜์ ์œผ๋กœ๋Š” 12-24์ฃผ๋ น์— ๊ฐ€๋Šฅ
  • ์ž ๋ณต๊ธฐ๋Š” ๋‹ค์–‘ํ•จ (๋ช‡ ์ฃผ)
  • ์‹ค์ œ case์—์„œ, ๋ฐฑ์‹  ์ ‘์ข…ํ•˜์ง€ ์•Š์€ ์‚ฐ๋ž€๊ณ„์—์„œ 3-4์ฃผ์— ์ฆ์ƒ ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ์œผ๋‚˜ ๋Œ€๋ถ€๋ถ„ 8-9์ฃผ ๋˜๋Š” ์‚ฐ๋ž€ ์‹œ์ž‘ ์‹œ๊ธฐ์— ์ฆ์ƒ์ด ๋‚˜ํƒ€๋‚จ.
    • molting(์‚ฐ๋ž€์œจ์˜ ํšŒ๋ณต์„ ์œ„ํ•ด ์ผ์ • ๊ธฐ๊ฐ„ ๋ฌผ๋งŒ ์ฃผ๋Š” ๊ฒƒ) โ†’ ๋ฉด์—ญ๋ ฅ์„ ๋–จ์–ด๋œจ๋ ค ๋งˆ๋ ‰๋ณ‘ ์ฆ์ƒ์ด ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ์Œ.
  • ํฌ๊ฒŒ 4๊ฐ€์ง€ form์œผ๋กœ ๋ถ„๋ฅ˜ ๊ฐ€๋Šฅ.
์ข…๋ฅ˜ํŠน์ง•
Classical formmild MDV์—์„œ ๋‚˜ํƒ€๋‚จ.
์‹ ๊ฒฝ ์นจํ•ด๊ฐ€ ์ฃผ ์ฆ์ƒ, ๋‹ค๋ฆฌ์™€ ๋‚ ๊ฐœ์˜ ๋งˆ๋น„.
- neck muscle ์‹ ๊ฒฝ ์นจํ•ด โ†’ bending head ๋˜๋Š” torticollis
- vagus nerve์— ์นจํ•ด โ†’ ํ˜ธํก๊ธฐ ๊ด€๋ จ ์ฆ์ƒ
Acute formvirulent MDV์—์„œ ๋‚˜ํƒ€๋‚จ.
๋‚ด์žฅ ๊ธฐ๊ด€์— lymphoma ํ˜•์„ฑ
- ์šฐ์šธ, ์ฒด์ค‘ ๊ฐ์†Œ, ๋ถˆ๋ฉด์ฆ, ์„ค์‚ฌ ๋“ฑ์˜ ์ฆ์„ธ
Acute cytolytic diseasevery virulent MDV์—์„œ ๋‚˜ํƒ€๋‚จ.
๋ฆผํ”„ ๊ธฐ๊ด€์˜ ์œ„์ถ•๊ณผ ํ•จ๊ป˜ ๊ธ‰์„ฑ ์„ธํฌ ์šฉํ•ด์„ฑ ์ฆ์„ธ.
- ๋ชฉ ์ฃผ์œ„์˜ thymus์—์„œ ์œ„์ถ•์ด ์‹ฌํ•จ
- 10-14์ผ๋ น์— ๋†’์€ mortality๋ฅผ ๊ฐ€์ง: โ€œearly mortality syndromeโ€
Transient paralysis
(์ผ๊ณผ์„ฑ ๋งˆ๋น„)
MDV์˜ ํ”ํ•˜์ง€ ์•Š์€ ์ž„์ƒ ์ฆ์„ธ.
5-18์ฃผ๋ น ์‚ฌ์ด์˜ ๋‹ญ์—์„œ, ๋ชฉ, ๋‚ ๊ฐœ, ๋‹ค๋ฆฌ์— ๋‹ค์–‘ํ•œ ์ •๋„์˜ ๋งˆ๋น„.
๊ฐ์—ผ ํ›„ 8-12์ผ์— ์ฃผ๋กœ ๋ณด์ด๋ฉฐ, 24-48์‹œ๊ฐ„ ์ฆ์ƒ ์ง€์†.

2) Gross lesions

Peripheral nerve
  • classical MD์— ์˜ํ•ด ์ฃผ๋กœ ์‹ ๊ฒฝ์˜ enlargement ๋ฐœ์ƒ
    • ์‹ ๊ฒฝ์ด 2~3๋ฐฐ ๋‘๊บผ์›Œ์ง€๋ฉฐ, ์™ธ๊ด€์ด ๋ณ€ํ•จ.
    • ์‹ ๊ฒฝ์˜ ์ƒ‰๊น”์ด yellow, gray color๋กœ ๋ณ€ํ•จ. (depigmentation)
  • ์ฃผ๋กœ ํŽธ์ธก์„ฑ์œผ๋กœ ์˜ด.
  • sciatic and brachial nerve์— ์˜ํ–ฅ์„ ๋ฏธ์นจ.
Visceral organs
  • lymphomatous lesions
    • ๋ฐฑํ˜ˆ๋ณ‘๋ณด๋‹ค ํ›จ์”ฌ ๋‹ค์–‘ํ•œ ์œ„์น˜์— ์ข…์–‘ : gonad, ํ, ์‹ฌ์žฅ, mesentery, ์‹ ์žฅ, ๊ฐ„, ๋น„์žฅ, bursa, ๊ฐ€์Šด์ƒ˜, ๋ถ€์‹ , ์ด์ž, proventriculus, intestine, ํ™์ฑ„, ๊ณจ๊ฒฉ๊ทผ, ํ”ผ๋ถ€
  • lymphoma๋Š” diffuse enlargement, white-grayish discoloration์˜ ํ˜•ํƒœ
  • ๊ฐ„์ด ์ •์ƒ ํ˜•ํƒœ๋ฅผ ๋ฒ—์–ด๋‚จ
  • ์ข…์–‘์ด ๋‚˜ํƒ€๋‚œ ๊ณณ์€ cauliflower-like appearance(์–‘๋ฐฐ์ถ” ๋ชจ์–‘ ์ข…์–‘)
  • proventriculus๋Š” ๋‘๊บผ์›Œ์ง, ๋”ฑ๋”ฑํ•จ.
  • classical MD์—์„œ๋Š” ์ž˜ ๋ฐœ์ƒํ•˜์ง€ ์•Š์œผ๋ฉฐ, acute MD์—์„œ๋Š” ์ฃผ๋กœ ํ”ผ๋ถ€, feather follicle ์ฃผ๋ณ€, bursa of Fabricious ์ฃผ๋ณ€์—์„œ ์ข…์–‘์ด ๋‚˜ํƒ€๋‚จ.
  • ๊ฐ„๊ณผ ๋น„์žฅ์˜ lymphomatous enlargement๋Š” ์„ฑ์ฒด์—์„œ ๋” ํ”ํ•จ.
Others
  • Transient paralysis
  • muscle wasting, gray eye, atrophy of the bursa or thymus ์ •๋„

3) ์กฐ์ง๋ณ‘๋ฆฌํ•™์  ์†Œ๊ฒฌ

Feather follicle epithelium (๊นƒํ„ธ ๋ชจ๋‚ญ)

  • ์ฃผ์š” ์ „์—ผ ๋งค๊ฐœ์ฒด
  • ์œ ์ผํ•œ cell-free infectious virus (cell-free๋Š” FFE์—์„œ ์œ ์ผํ•˜๊ฒŒ ๊ฐ์—ผ์„ฑ์„ ๊ฐ€์ง)
  • ๋ฐ”์ด๋Ÿฌ์Šค์˜ ๋ณต์ œ์— ๋”ฐ๋ผ ์ƒํ”ผ๊ฐ€ ์†์ƒ๋จ
    • FFE์˜ infection๊ณผ degeneration
    • ํ”ผ๋ถ€ ํ˜ˆ๊ด€ ๊ทผ์ฒ˜ lymphoproliferative tissue์˜ accumulation (์ƒํ”ผ ์†์ƒ)
  • ๊ณจ์ˆ˜๋Š” MDV ๊ฐ์—ผ 5์ผ ํ›„ ๊ฐ์—ผ๋จ, RBC count์˜ ๊ฐ์†Œ๋กœ ์ด์–ด์ง.
  • ๋ชจ์ฒด์ดํ–‰ํ•ญ์ฒด๊ฐ€ ๋ถ€์กฑํ•˜๋ฉด marrow aplasia, marked anemia
๋ถ€์œ„ํŠน์ง•
Peripheral nerves- neoplastic lymphoproliferation : T cell์ด ์ข…์–‘ํ™”, ์‹ ๊ฒฝ์— infiltration
- A-type lesions : ๊ณผ์ฆ์‹๋œ T cell์ด ๋“ค์–ด๊ฐ€์„œ ๋ถ€ํ”ผ ์ฆ๊ฐ€ (ํŒ…ํŒ… ๋ถ€์Œ)
- B-type lesions : A type์— ์˜ํ•ด ๋ถ€์ฐจ์ ์œผ๋กœ ๋ฐœ์ƒ. ๋ฆผํ”„๊ตฌ ์นจ์ฐฉ์— ๋”ฐ๋ฅธ ์—ผ์ฆ ๋ฐ˜์‘ โ†’ ์‹ ๊ฒฝ์—ผ์„ฑ ๋ถ€์ข…(interneuritic edema)
CNS- ํ˜ˆ๊ด€ ์ฃผ๋ณ€๋ถ€ ๋ฆผํ”„๊ตฌ ์นจ์œค โ†’ ์ผ์‹œ์  ๋งˆ๋น„ ์ฆ์ƒ(transient paralysis)
- perivascular cuffing
Lymphomas- MD cells^[lymphocytes, lymphoblasts, reticulum cells, macrophages, degenerative lymphoblast]๋ฅผ ์ข…์–‘ํ™” โ†’ ์—ฌ๋Ÿฌ ์„ธํฌ๋“ค์ด ์„ž์ž„, mixture
์ฐธ๊ณ : Leukosis๋กœ ์ธํ•œ ์ข…์–‘์€ retrovirus๊ฐ€ ํŠน์ • ์„ธํฌ๋ฅผ ์ข…์–‘ํ™”์‹œํ‚ค๋ฏ€๋กœ ๋‹จ์ผ ์„ธํฌ
Ocular changes๋ฉด์—ญ ๊ด€๋ จ ์„ธํฌ๋“ค์ด ๋ˆˆ ์•ˆ์ชฝ์— ์นจ์ฐฉ
Vascular syndromes- ์ž์ฃผ ๋‚˜ํƒ€๋‚˜์ง€ ์•Š์Œ. ๋™๋งฅ๊ฒฝํ™” ์ •๋„.

4) Factors

  1. Virus strain and dose
    1. very highly
    2. highly (vvMDV)
    3. classic (vMDV)
  2. Host genotype, age, sex
    • ์œ ์ „๊ณผ ๋ฐ€์ ‘ํ•œ ์—ฐ๊ด€ (โ€˜์ฝ”๋ธŒโ€™๋ผ๋Š” ํŠน์ • ์œก๊ณ„ ์ข…์ด ์ž˜ ๊ฑธ๋ฆผ)
    • ์•”์ˆ˜๋Š” ํฐ ์˜๋ฏธ ์—†์œผ๋‚˜, ์ข…์–‘ ๋ฐœํ˜„์€ ๋‚œ์†Œ > testis
  3. ์ˆ™์ฃผ์˜ ๋ฉด์—ญ ์ƒํƒœ
    • ์—„๋งˆ์˜ ํš๋“ ๋ฉด์—ญ์ด ๋ชจ์ฒด์ดํ–‰ํ•ญ์ฒด๋ฅผ ํ†ตํ•ด ํ›„๋Œ€ ๋ณ‘์•„๋ฆฌ๋กœ ์ดํ–‰.
    • humoral๋ณด๋‹ค cell-mediated ๋ฉด์—ญ์ด ์ค‘์š” โ†’ IBD๋‚˜ CAV๋งŒํผ ๋ชจ์ฒด์ดํ–‰ํ•ญ์ฒด๊ฐ€ ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•˜์ง€๋Š” ์•Š์Œ.
    • ์ˆ˜๋™ ๋ฉด์—ญ์€ 3์ฃผ ์ •๋„ ์ง€์† : 4๊ฐ€์ง€ ๊ธฐ๋Šฅ
        1. acute cytolytic infection์˜ ์ •๋„๋ฅผ ๋‚ฎ์ถค
        1. ๋ฆผํ”„๊ตฌ ํ˜•์„ฑ์„ ๊ฐ์†Œ (ํฐ ์˜๋ฏธ ์—†์Œ)
        1. ์งˆ๋ณ‘ ๋ฐœ์ƒ๊ณผ ์‚ฌ๋ง์— ์ด๋ฅด๋Š” ๊ธฐ๊ฐ„์„ ์ง€์—ฐ์‹œํ‚ด
        1. mortality๋ฅผ ๊ฐ์†Œ์‹œํ‚ด
    • HVT์˜ ๊ฐ์—ผ, no oncogenic MDV(SB-1)์˜ ๊ฐ์—ผ : ๋ณต์ œ๋ฅผ ํ•˜๊ธด ํ•˜๋Š”๋ฐ, cytolytic infection๊นŒ์ง€๋Š” ์•„๋‹˜. ๋ฉด์—ญ ์–ต์ œ๋Š” ์•„๋‹˜.
  4. ์ŠคํŠธ๋ ˆ์Šค
    • ์‚ฐ๋ž€ ์‹œ๊ธฐ์— ์ŠคํŠธ๋ ˆ์Šค ๊ด€๋ฆฌ๊ฐ€ ์ž˜ ๋˜๋ฉด ํ์‚ฌ์œจ ๋‚ฎ์Œ. ๋ฐ˜๋Œ€๋„ ๋งˆ์ฐฌ๊ฐ€์ง€.
    • ์ŠคํŠธ๋ ˆ์Šค๊ฐ€ ๋งค์šฐ ํฐ ์š”์ธ

5) MD infection์˜ ๋‹จ๊ณ„

Phase 1 (Early=Semi Productive-restrictive infection)

  • ํ˜ธํก๊ธฐ๋ฅผ ํ†ตํ•ด ๋ฆผํ”„ ๊ธฐ๊ด€์— ๋ฐ”์ด๋Ÿฌ์Šค(cell-free) ์นจ์ž….
  • ==primary target cell์€ spleen, bursa, thymus์˜ B cells.==
  • ๋ฆผํ”„ ๊ธฐ๊ด€(ํŠนํžˆ ํ‰์„ ๊ณผ F๋‚ญ)์˜ ์ผ์‹œ์  ์œ„์ถ•.
  • ๋ฆผํ”„๊ตฌ์˜ apoptosis โ†’ ๋ฉด์—ญ ์–ต์ œ๊ฐ€ ์ผ์–ด๋‚จ.
  • ์ดํ›„ latent infection์œผ๋กœ ๋„˜์–ด๊ฐ.

Phase 2 (latent infection)

  • activated CD4+ T cell์ด ๊ฐ€์žฅ ์˜ํ–ฅ ๋ฐ›์Œ.

Phase 3 (Second Phase of Cytolytic Infection)

  • second wave๋กœ ๋ฉด์—ญ ์–ต์ œ๊ฐ€ ๋” ์‹ฌํ•ด์ง
  • vvMD ๋˜๋Š” vv+MD์—์„œ ๋‘ ๋ฒˆ์งธ cytolytic infection์ด ๋‚˜ํƒ€๋‚˜๊ธฐ๋„ ํ•จ.
  • pathotype์ด ๋†’์€ ๋ฐ”์ด๋Ÿฌ์Šค์— ๊ฐ์—ผ๋˜์—ˆ๊ฑฐ๋‚˜, ์ˆ™์ฃผ๊ฐ€ ๊ฐ์ˆ˜์„ฑ์ด ๋†’์€ ์ข…์ด๊ฑฐ๋‚˜.

Fully productive infection (=Cytolytic Infection)

  • ๊ฐ์—ผ๋œ ๋ฆผํ”„๊ตฌ๋ฅผ ํ†ตํ•ด FFE๋กœ ์ด๋™
  • ๊ทธ ์ž์ฒด๋กœ, ์„ธํฌ์™€ ๊ด€๊ณ„์—†์ด(cell-free) ๊ฐ์—ผ์„ฑ์„ ๊ฐ€์ง€๋Š” ๋ฐ”์ด๋Ÿฌ์Šค๋ฅผ ์ƒ์‚ฐํ•œ๋‹ค.

Phase 4 (Development of Lymphomas)

  • ๋ฆผํ”„๊ตฌ๊ฐ€ ํŠน์ • ์žฅ๊ธฐ์— ๊ณผ์ฆ์‹ํ•˜๋ฉด์„œ ์ข…์–‘์„ ํ˜•์„ฑ
  • lymphoma๊ฐ€ ๋‚˜ํƒ€๋‚˜๋ฉด 3-4์ฃผ ์•ˆ์— ํ์‚ฌ
  • lymphoma transformation์˜ ์กฐ๊ฑด (์ค‘์š”X)
    • lasting T cell์€ ๋‚˜ํƒ€๋‚˜์ง€ ์•Š๊ณ , activation๋œ T cell๋งŒ ๋‚˜ํƒ€๋‚จ

โ…ค. Epizootiology

  • ๋‹ญ๊ณผ ๋™๋ฌผ์— ์ฃผ๋กœ ๊ฐ์—ผ๋จ.

  • ์–ด๋А ์ผ๋ น์—๋‚˜ ๊ฐ์—ผ๋  ์ˆ˜ ์žˆ์ง€๋งŒ, ์ดˆ๊ธฐ ๋ช‡ ์ฃผ๊ฐ„ ๋Œ€๋ถ€๋ถ„ ๊ฐ์—ผ ๋ฐœ์ƒ

  • 4๋„์—์„œ๋Š” ์ˆ˜๋…„๊ฐ„, 20-25๋„์—์„œ๋„ ์ˆ˜ ๊ฐœ์›”

  • vertical transmission์€ ์ผ์–ด๋‚˜์ง€ ์•Š์Œ

  • Horizontal spread : ๋ฐ”์ด๋Ÿฌ์Šค๊ฐ€ ๋ฌป์€ dander, litter ๊ฐ™์€ ์ง€์ €๋ถ„ํ•œ ๋ฌผ์ฒด๋“ค

โ…ฅ. Diagnosis, Prevention

  • ๋งˆ๋ ‰ ์ง„๋‹จ ์–ด๋ ค์›€. LL๊ณผ ์ข…์–‘ ์–‘์ƒ ๋น„์Šท.
  • ํ•˜์ง€๋งŒ ์ž„์ƒ์—์„œ ์ข…์–‘์„ ๋งŒ๋‚ฌ๋‹ค? ๋งˆ๋ ‰์œผ๋กœ ๋ด๋„ ๊ฑฐ์˜ ํ‹€๋ฆฌ์ง€ ์•Š์Œ..

1) ์ž„์ƒ ์ฆ์ƒ, ๋ถ€๊ฒ€ ์†Œ๊ฒฌ

  • dehydration, starvation์— ์˜ํ•ด ํ์‚ฌ
  • ๋ง์ดˆ์‹ ๊ฒฝ์˜ enlargement
  • (MD์ด๋“  LL์ด๋“  ์–ด๋””๋“  tumor๊ฐ€ ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ๋‹ค)
  • MATSA ์กด์žฌ ์—ฌ๋ถ€ ํ™•์ธ (์‹œ์•ฝ ์ด์šฉ)
  • lymphoid leukosis๊ฐ€ ๊ฐ€์žฅ ํ”ํ•œ ๊ฐ๋ณ„ ์ง„๋‹จ

2) Isolation & Identification

  • Buffy coat cell
  • cell culture ์‹œ์Šคํ…œ์„ ๊ฐ€์žฅ ๋งŽ์ด ์“ด๋‹ค
    • serotype 1 : DEF(duck embryo fibroblast)๋‚˜ CKC(chicken kidney cell)์—์„œ ์ž˜ ์ž๋žŒ
    • serotype 2&3 : CEF(chicken embryo fibroblast)
  • FFE ๋์— ๊ณ ์—ฌ ์žˆ๋Š” ์•ก์ฒด์—์„œ ๊ท  ๊ฒ€์ถœ
  • 1์ผ๋ น์— ๋ฐฑ์‹  ์ ‘์ข… ์‹œ ์ฆ์ƒ์ด ๋‚˜์˜ค๋Š”์ง€ ์•ˆ ๋‚˜์˜ค๋Š”์ง€ ํ™•์ธ
  • serotype 1 ์ค‘ oncogenic strain / attenuated strain ์ค‘ ์–ด๋–ค ๊ฒŒ ์งˆ๋ณ‘์ด๊ณ  ์–ด๋–ค ๊ฒŒ ๋ฐฑ์‹ ์ธ์ง€ ๊ฐ๋ณ„ ํ•„์š” : 132bp related gene์„ ๊ฐ€์ง€๋ฉด attenuated ์•ˆ ๋œ ๊ฒƒ.

3) Vaccination

  • 1์ผ๋ น์— ์ ‘์ข…ํ•˜๋ฉด ์ „ ์ƒ์•  ๋ฉด์—ญ
  • serotype 1
  • serotype 2 : SB-1
  • serotype 3 : HVT
  • polyvalent : HVT+SB-1
  • recombinant vaccine (serotype 1+3)^[Herpes๋Š” ํฌ๊ธฐ๊ฐ€ ํฌ๋‹ค-nonessential region์ด ๋งŽ์Œ. HVT ์œ ์ „์ž์— VP2๋ฅผ ์ง‘์–ด๋„ฃ์œผ๋ฉด VP2 protein๋„ ๋ฐœํ˜„ํ•œ๋‹ค. ๊ทธ๋Ÿผ ํ•ญ์ฒด๋ฅผ ๋งŒ๋“ค๊ฒŒ ๋œ๋‹ค. ๊ทธ๋Ÿผ VP2 ๋‹จ๋ฐฑ์งˆ์— ๋Œ€ํ•œ ํ•ญ์ฒด๊ฐ€ ์žˆ์œผ๋‹ˆ IBD๋„ ๋ฉด์—ญ๋จ. ์ฆ‰, ํ•œ ๋ฐฑ์‹ ์œผ๋กœ Marek๋„, IBD๋„ ๋ง‰๋Š” ๊ฒƒ. ์ด๋Ÿฐ ์‹์œผ๋กœ ๊ณ„์† ์šฑ์—ฌ๋„ฃ๋‹ค ๋ณด๋ฉด ์—ฌ๋Ÿฌ ๋ฐ”์ด๋Ÿฌ์Šค์— ๋Œ€ํ•œ ํ•ญ์ฒด๊ฐ€ ๋–จ์–ด์ง€์ง€ ์•Š๊ณ  ์ƒ์Šน. ๊ต‰์žฅํžˆ ๋งŽ์ด ์‚ฌ์šฉ๋˜๊ณ  ์žˆ์Œ.]